Trial NCT01539018

View at ClinicalTrials.gov 
Org. Study IDs: ESLC1 (SADAT study)

Last trial update was posted on 2015-08-05

MeSH Interventions

Sorafenib Tegafur

MeSH Conditions

Carcinoma, Hepatocellular

Other Conditions

Advanced Hepatocellular Carcinoma

Stopping Reasons

After interim results data showed no evidence of a difference between both groups

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID